Article
Greg Foltz, MD, Director, Center for Advanced Brain Tumor Treatment, Swedish Neuroscience Institute, Seattle, WA, discusses current treatments for brain cancer.
FDA Approves Eplontersen (Wainua) for ATTRv Polyneuropathy
Rare Disease Report Podcast: CDKL5 Deficiency Disorder Expert Interview
Changes in the Diagnostic Process of Alzheimer Disease: A New Era of Blood-Based Approaches
The Rare Disease Report Podcast: Adrenomyeloneuropathy
Retinal Vein Occlusion Could Serve as Age-Dependent Risk Factor for Dementia
In Heart Failure Patients, Spironolactone Linked to Reduced Risk of Dementia, Alzheimers Disease